PAMU
ARIA

Pictet Asset Management (UK)’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Pictet Asset Management (UK)’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,515,257
Closed -$18.9M – 888
2016
Q4 		$18.9M Buy
+1,515,257
New +$18.2M 0.07% 335
2013
Q4 		– Sell
-167,300
Closed -$3.08M – 892
2013
Q3 		$3.08M Buy
167,300
+10,200
+6% +$198K 0.02% 640
2013
Q2 		$2.75M Buy
+157,100
New +$2.79M 0.02% 642

Other funds holding ARIA

FPF
FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return

Pictet Asset Management (UK)'s ARIA Position: Q1 2017 in Review

Pictet Asset Management (UK) sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 1,515,257 shares — an estimated $18.9M sold.

Pictet Asset Management (UK) first reported a position in ARIA in Q2 2013 and held it in 3 quarters. The position peaked at $18.9M in Q4 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

  • Pictet Asset Management (UK) reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
  • Pictet Asset Management (UK) sold 1,515,257 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $18.9M.
  • Pictet Asset Management (UK) first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 3 quarters.
  • Pictet Asset Management (UK)'s Ariad Pharmaceuticals Inc position peaked at $18.9M in Q4 2016.
  • 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Pictet Asset Management (UK)'s 13F filing for Q1 2017, filed 4 May 2017.